Hims & Hers Health Inc [NYSE: HIMS] closed the trading session at $23.05.
The stocks have a year to date performance of 158.99 percent and weekly performance of 12.44 percent. The stock has been moved at 94.02 percent over the last six months. The stock has performed 41.41 percent around the most recent 30 days and changed 1.23 percent over the most recent 3-months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If compared to the average trading volume of 9.90M shares, HIMS reached to a volume of 8019365 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Hims & Hers Health Inc [HIMS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HIMS shares is $21.69 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HIMS stock is a recommendation set at 2.23. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Needham have made an estimate for Hims & Hers Health Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 22, 2024. The new note on the price target was released on August 09, 2024, representing the official price target for Hims & Hers Health Inc stock. Previously, the target price had yet another raise from $16 to $20, while Citigroup kept a Neutral rating on HIMS stock. On April 16, 2024, analysts decreased their price target for HIMS shares from 17 to 15.
The Average True Range (ATR) for Hims & Hers Health Inc is set at 1.31, with the Price to Sales ratio for HIMS stock in the period of the last 12 months amounting to 4.68. The Price to Book ratio for the last quarter was 13.81, with the Price to Cash per share for the same quarter was set at 1.05. Price to Free Cash Flow for HIMS in the course of the last twelve months was 55.74 with Quick ratio for the last quarter at 2.30.
HIMS stock trade performance evaluation
Hims & Hers Health Inc [HIMS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 12.44. With this latest performance, HIMS shares gained by 41.41% in over the last four-week period, additionally plugging by 94.02% over the last 6 months – not to mention a rise of 280.99% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HIMS stock in for the last two-week period is set at 68.76, with the RSI for the last a single of trading hit 71.46, and the three-weeks RSI is set at 65.74 for Hims & Hers Health Inc [HIMS]. The present Moving Average for the last 50 days of trading for this stock 17.11, while it was recorded at 22.38 for the last single week of trading, and 15.77 for the last 200 days.
Hims & Hers Health Inc [HIMS]: An insightful look at the core fundamentals
Hims & Hers Health Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.30 and a Current Ratio set at 2.68.
Earnings per share (EPS) analysis for Hims & Hers Health Inc [HIMS] stock
With the latest financial reports released by the company, Hims & Hers Health Inc posted -0.04/share EPS, while the average EPS was predicted by analysts to be reported at -0.03/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.01. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HIMS.
Hims & Hers Health Inc [HIMS]: Institutional Ownership
There are presently around $66.83%, or 75.93%% of HIMS stock, in the hands of institutional investors. The top three institutional holders of HIMS stocks are: VANGUARD GROUP INC with ownership of 16.47 million shares, which is approximately 7.7166%. BLACKROCK INC., holding 14.57 million shares of the stock with an approximate value of $$294.25 million in HIMS stocks shares; and BLACKROCK INC., currently with $$121.94 million in HIMS stock with ownership which is approximately 2.8294%.
